CIT Pharmacology & Medications in Implantology 2

Question 1

Patients taking bisphosphonate medications (e.g., alendronate) present an elevated risk for which serious implant-related complication?

Accepted Answer

Medication-related osteonecrosis of the jaw (MRONJ)

Answer

Bisphosphonates inhibit osteoclast activity, which can impair bone remodeling and blood supply, increasing risk of osteonecrosis, especially after surgical trauma.

Question 2

Which corticosteroid is sometimes prescribed pre-operatively before implant placement to reduce post-surgical edema?

Accepted Answer

Dexamethasone 4–8 mg single dose

Answer

A single pre-operative dose of dexamethasone 4–8 mg reduces post-surgical swelling and trismus without significantly suppressing the immune response.

Question 3

Which hemostatic agent can be placed directly into the implant socket to aid in bleeding control during implant placement?

Accepted Answer

Oxidized regenerated cellulose (e.g., Surgicel)

Answer

Oxidized regenerated cellulose is a resorbable hemostatic material that can be placed in the surgical site to mechanically and chemically promote clot formation.

Question 4

A patient taking warfarin is scheduled for implant surgery. The primary concern with this medication is:

Accepted Answer

Prolonged bleeding and difficulty achieving hemostasis

Answer

Warfarin inhibits vitamin K-dependent clotting factors, significantly prolonging bleeding time and making intraoperative and post-operative hemostasis more challenging.

Question 5

Which NSAID should be avoided in patients with known aspirin sensitivity who require post-implant pain management?

Accepted Answer

Ketorolac

Answer

Ketorolac is an NSAID that can trigger cross-reactive hypersensitivity (aspirin-exacerbated respiratory disease) in aspirin-sensitive patients and should be avoided.

(CIT) Certified Implantology Technician Practice Test

(CIT) Certified Implantology Technician Practice Test

CIT Pharmacology & Medications in Implantology 2